@article{article, title  = {{SunRISe-3: TAR-200 plus cetrelimab or TAR-200 versus intravesical Bacillus Calmette–Guérin in patients with BCG-naive high-risk non–muscle-invasive bladder cancer}},

 publisher = {{Elsevier BV}},

 url = {{http://dx.doi.org/10.1016/s0302-2838(24)01168-0 }},

 year = {{2024}},

 month = {{3}},

 author = {{Catto JWF and Necchi A and Powles T and Guerrero-Ramos F and Simone G and Shore N and Salinas JS and Merseburger AS and Roumiguie M and Hiroshi K and Morris DM et al}},

 doi = {{10.1016/s0302-2838(24)01168-0}},

 volume = {{85}},

 journal = {{European Urology}},

 pages = {{S1505-S1505}},

 note = {{Accessed on 2024/12/26}}}